title: [How should risk be reported?].
authors.affiliation: Aalborg Sygehus, Klinisk Epidemiologisk Afdeling. uxgln@aas.nja.dk
authors.forename: Gunnar Lauge
authors.initials: GL
authors.lastname: Nielsen
authors.forename: Ulrik
authors.initials: U
authors.lastname: Tage-Jensen
authors.forename: Torsten Toftegaard
authors.initials: TT
authors.lastname: Nielsen
authors.forename: Henrik Toft
authors.initials: HT
authors.lastname: Sørensen
mesh_terms: D003657:Decision Making; D018572:Disease-Free Survival; D006801:Humans; D008017:Life Expectancy; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D016896:Treatment Outcome